137 related articles for article (PubMed ID: 36907294)
1. Conjugation of folic acid with poly (NVCL-co-PEGMA)-grafted chitosan as a new doxorubicin delivery system.
Panahi M; Rahbari-Sisakht M; Faramarzi M
Int J Biol Macromol; 2023 May; 236():123933. PubMed ID: 36907294
[TBL] [Abstract][Full Text] [Related]
2. Fabrication of biocompatible magnetic maltose/MIL-88 metal-organic frameworks decorated with folic acid-chitosan for targeted and pH-responsive controlled release of doxorubicin.
Karimi S; Namazi H
Int J Pharm; 2023 Mar; 634():122675. PubMed ID: 36736967
[TBL] [Abstract][Full Text] [Related]
3. Folic acid conjugated poly (Amidoamine) dendrimer grafted magnetic chitosan as a smart drug delivery platform for doxorubicin: In-vitro drug release and cytotoxicity studies.
Soltany P; Miralinaghi M; Pajoum Shariati F
Int J Biol Macromol; 2024 Feb; 257(Pt 1):127564. PubMed ID: 37865361
[TBL] [Abstract][Full Text] [Related]
4. Folic acid conjugated palygorskite/Au hybrid microgels: Temperature, pH and light triple-responsive and its application in drug delivery.
Liu L; Liu YX; Zhong H; Li XR; Jun YL; Wang QL; Ding LS; Cheng ZP; Qian HY
Colloids Surf B Biointerfaces; 2023 Sep; 229():113432. PubMed ID: 37422992
[TBL] [Abstract][Full Text] [Related]
5. pH-responsive glycodendrimer as a new active targeting agent for doxorubicin delivery.
Soltani A; Faramarzi M; Farjadian F; Parsa SAM; Panahi HA
Int J Biol Macromol; 2022 Nov; 221():508-522. PubMed ID: 36089082
[TBL] [Abstract][Full Text] [Related]
6. Chitosan Immobilization on Bio-MOF Nanostructures: A Biocompatible pH-Responsive Nanocarrier for Doxorubicin Release on MCF-7 Cell Lines of Human Breast Cancer.
Abazari R; Mahjoub AR; Ataei F; Morsali A; Carpenter-Warren CL; Mehdizadeh K; Slawin AMZ
Inorg Chem; 2018 Nov; 57(21):13364-13379. PubMed ID: 30351060
[TBL] [Abstract][Full Text] [Related]
7. Folate-decorated PEGylated triblock copolymer as a pH/reduction dual-responsive nanovehicle for targeted intracellular co-delivery of doxorubicin and Bcl-2 siRNA.
Suo A; Qian J; Xu M; Xu W; Zhang Y; Yao Y
Mater Sci Eng C Mater Biol Appl; 2017 Jul; 76():659-672. PubMed ID: 28482576
[TBL] [Abstract][Full Text] [Related]
8. Smart co-delivery of plasmid DNA and doxorubicin using MCM-chitosan-PEG polymerization functionalized with MUC-1 aptamer against breast cancer.
Esmaeili Y; Dabiri A; Mashayekhi F; Rahimmanesh I; Bidram E; Karbasi S; Rafienia M; Javanmard SH; Ertas YN; Zarrabi A; Shariati L
Biomed Pharmacother; 2024 Apr; 173():116465. PubMed ID: 38507955
[TBL] [Abstract][Full Text] [Related]
9. UiO-66 metal organic framework nanoparticles loaded carboxymethyl chitosan/poly ethylene oxide/polyurethane core-shell nanofibers for controlled release of doxorubicin and folic acid.
Farboudi A; Mahboobnia K; Chogan F; Karimi M; Askari A; Banihashem S; Davaran S; Irani M
Int J Biol Macromol; 2020 May; 150():178-188. PubMed ID: 32045607
[TBL] [Abstract][Full Text] [Related]
10. Doxorubicin and siRNA Codelivery via Chitosan-Coated pH-Responsive Mixed Micellar Polyplexes for Enhanced Cancer Therapy in Multidrug-Resistant Tumors.
Butt AM; Amin MC; Katas H; Abdul Murad NA; Jamal R; Kesharwani P
Mol Pharm; 2016 Dec; 13(12):4179-4190. PubMed ID: 27934479
[TBL] [Abstract][Full Text] [Related]
11. Smart chitosan-folate hybrid magnetic nanoparticles for targeted delivery of doxorubicin to osteosarcoma cells.
Amiryaghoubi N; Abdolahinia ED; Nakhlband A; Aslzad S; Fathi M; Barar J; Omidi Y
Colloids Surf B Biointerfaces; 2022 Dec; 220():112911. PubMed ID: 36274396
[TBL] [Abstract][Full Text] [Related]
12. Preparation of Modified Chitosan-based Nanoparticles for Efficient Delivery of Doxorubicin and/or Cisplatin to Breast Cancer Cells.
Matalqah SM; Aiedeh K; Mhaidat NM; Alzoubi KH; Al-Husein BA
Curr Cancer Drug Targets; 2022; 22(2):133-141. PubMed ID: 35081892
[TBL] [Abstract][Full Text] [Related]
13. Folic acid conjugated glycol chitosan micelles for targeted delivery of doxorubicin: preparation and preliminary evaluation in vitro.
Yu J; Xie X; Wu J; Liu Y; Liu P; Xu X; Yu H; Lu L; Che X
J Biomater Sci Polym Ed; 2013; 24(5):606-20. PubMed ID: 23565871
[TBL] [Abstract][Full Text] [Related]
14. Dual thermo-and pH-sensitive injectable hydrogels of chitosan/(poly(N-isopropylacrylamide-co-itaconic acid)) for doxorubicin delivery in breast cancer.
Fathi M; Alami-Milani M; Geranmayeh MH; Barar J; Erfan-Niya H; Omidi Y
Int J Biol Macromol; 2019 May; 128():957-964. PubMed ID: 30685304
[TBL] [Abstract][Full Text] [Related]
15. pH and folic acid dual responsive polysaccharide nanospheres used for nuclear targeted cancer chemotherapy.
Ren X; He L; Tian X; Zhang P; Chen Z; Mei X
Colloids Surf B Biointerfaces; 2019 Jun; 178():445-451. PubMed ID: 30921679
[TBL] [Abstract][Full Text] [Related]
16. [Synthesis of folate modified chitosan-based nanomicelles and its
Liu L; Huang G; Bai H; Tang G
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2020 May; 49(3):364-374. PubMed ID: 32762172
[TBL] [Abstract][Full Text] [Related]
17. Co-delivery of doxorubicin and interleukin-2 via chitosan based nanoparticles for enhanced antitumor efficacy.
Wu J; Tang C; Yin C
Acta Biomater; 2017 Jan; 47():81-90. PubMed ID: 27729232
[TBL] [Abstract][Full Text] [Related]
18. A chitosan/mesoporous silica nanoparticle-based anticancer drug delivery system with a "tumor-triggered targeting" property.
Liao T; Liu C; Ren J; Chen H; Kuang Y; Jiang B; Chen J; Sun Z; Li C
Int J Biol Macromol; 2021 Jul; 183():2017-2029. PubMed ID: 34097958
[TBL] [Abstract][Full Text] [Related]
19. A novel delivery system of doxorubicin with high load and pH-responsive release from the nanoparticles of poly (α,β-aspartic acid) derivative.
Wang X; Wu G; Lu C; Zhao W; Wang Y; Fan Y; Gao H; Ma J
Eur J Pharm Sci; 2012 Aug; 47(1):256-64. PubMed ID: 22522116
[TBL] [Abstract][Full Text] [Related]
20. Characterization and Evaluation of Bone-Derived Nanoparticles as a Novel pH-Responsive Carrier for Delivery of Doxorubicin into Breast Cancer Cells.
Haque ST; Islam RA; Gan SH; Chowdhury EH
Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32937817
[No Abstract] [Full Text] [Related]
[Next] [New Search]